Arab Republic of Egypt - Health Survey for the Egyptian Households 2021
Reference ID | EGY-CAPMAS-EFHS2021-v02 |
Year | 2021 |
Country | Arab Republic of Egypt |
Producer(s) | CAPMAS |
Sponsor(s) | Egyptian Government - - |
Collection(s) |
Created on
Oct 18, 2023
Last modified
Oct 18, 2023
Page views
577430
Brand name of pills reported
(Q306)
File: WOMEN
File: WOMEN
Overview
Type:
Discrete Format: numeric Width: 2 Decimals: 0 Range: 1-98 | Valid cases: 3690 Invalid: 17577 |
Value | Category | Cases | |
---|---|---|---|
1 | Microcept | 1406 | 38.1% |
2 | Microlut | 257 | 7.0% |
3 | Levonor | 269 | 7.3% |
4 | Triocept | 54 | 1.5% |
5 | Gynera | 693 | 18.8% |
6 | Nordette | 9 | 0.2% |
7 | Exluton | 154 | 4.2% |
8 | Marvelon | 15 | 0.4% |
9 | Cilest | 25 | 0.7% |
10 | Cotrablan | 8 | 0.2% |
96 | Other | 438 | 11.9% |
98 | Don't know | 362 | 9.8% |
Sysmiss | 17577 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.